Astria Therapeutics, Inc. (ATXS) Total Assets by Year
Astria Therapeutics, Inc. closed fiscal year 2024 with $342.4M in total assets, $23.1M in total liabilities and $319.3M in shareholder equity. This represents an increase of 34.4% from the prior fiscal year. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters Astria Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ATXS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $342.4M+34.4% | $254.7M+10.4% | $230.6M+80.9% | $127.5M+168.7% | $47.5M+13.6% | $41.8M+6.7% | $39.2M+118.9% | $17.9M-55.5% | $40.2M-37.3% | $64.2M+302.0% | $16.0M | N/A |
| Total Liabilities | $23.1M+100.0% | $11.6M+22.7% | $9.4M+81.0% | $5.2M-23.3% | $6.8M+12.0% | $6.1M+43.4% | $4.2M-30.8% | $6.1M-45.1% | $11.1M-18.7% | $13.7M-84.6% | $89.0M | N/A |
| Total Equity | $319.3M+31.3% | $243.1M+9.9% | $221.2M+80.9% | $122.3M+200.7% | $40.7M+13.9% | $35.7M+2.2% | $34.9M+196.3% | $11.8M-59.5% | $29.1M-42.4% | $50.5M+169.1% | -$73.1M-40.0% | -$52.2M |
ATXS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $271.9M-24.8% | $281.9M-23.4% | $310.4M-18.1% | $342.4M+34.4% | $361.6M+86.5% | $368.0M+77.7% | $378.8M+73.6% | $254.7M+10.4% | $193.9M+61.8% | $207.1M+96.6% | $218.2M+90.3% | $230.6M+80.9% |
| Total Liabilities | $38.6M+93.2% | $21.4M+2.4% | $21.1M+90.5% | $23.1M+100.0% | $20.0M+113.0% | $20.9M+214.4% | $11.1M+60.9% | $11.6M+22.7% | $9.4M+35.1% | $6.7M+13.2% | $6.9M+38.5% | $9.4M+81.0% |
| Total Equity | $233.3M-31.7% | $260.5M-24.9% | $289.3M-21.3% | $319.3M+31.3% | $341.7M+85.2% | $347.1M+73.2% | $367.7M+74.0% | $243.1M+9.9% | $184.5M+63.4% | $200.4M+101.6% | $211.4M+92.7% | $221.2M+80.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Astria Therapeutics, Inc. financials
Frequently Asked Questions
What was Astria Therapeutics, Inc.'s total assets in fiscal year 2024?
Astria Therapeutics, Inc. closed fiscal year 2024 with $342.4M in total assets, $23.1M in total liabilities and $319.3M in shareholder equity.
How fast is Astria Therapeutics, Inc.'s total assets growing?
Astria Therapeutics, Inc. (ATXS) total assets rose by 34.4% year over year, from $254.7M to $342.4M in fiscal year 2024.
What was Astria Therapeutics, Inc.'s total assets in the most recent quarter?
Astria Therapeutics, Inc. (ATXS) reported $271.9M in total assets in Q3 2025. This represents a decrease of 24.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Astria Therapeutics, Inc. (ATXS) reported on that line in every period on record.